Cargando…
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
INTRODUCTION: Gout is commonly associated with low adherence rates, thus limiting the effectiveness of treatment. Nevertheless, informed and empowered patients may be more likely to achieve high adherence. We intend to demonstrate that adherence in clinical practice may reach that achieved in clinic...
Autores principales: | Perez-Ruiz, Fernando, Perez-Herrero, Nuria, Richette, Pascal, Stack, Austin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695758/ https://www.ncbi.nlm.nih.gov/pubmed/33111171 http://dx.doi.org/10.1007/s40744-020-00249-w |
Ejemplares similares
-
Who’s to blame for central venous stenosis
por: Li, Xiaodong, et al.
Publicado: (2023) -
Adherence with urate-lowering therapies for the treatment of gout
por: Harrold, Leslie R, et al.
Publicado: (2009) -
Treatment approaches and adherence to urate-lowering therapy for patients with gout
por: Aung, Thanda, et al.
Publicado: (2017) -
Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis
por: Yin, Rulan, et al.
Publicado: (2018) -
Variation in serum urate levels in the absence of gout and urate lowering therapy
por: Shaffer, Andrew, et al.
Publicado: (2021)